Regulations consolidate Welsh market entry rules

摘要

CHANGES to the market entry approach in Wales and a regulatory framework for fitness-to-practise criteria are included in new pharmaceutical services Regulations that came into force last week. The National Health Service (Pharmaceutical Services) (Wales) Regulations 2013 replace the National Health Service (Pharmaceutical Services) Regulations 1992. According to the Welsh Government, the new Regulations (see Panel) are intended to "allow for a structured approach in determining where NHS pharmaceutical services are located in Wales and also reduce the administrative burden on local health boards associated with processing applications to provide NHS pharmaceutical services and on the Welsh ministers in processing subsequent appeals".